Gain Therapeutics, Inc. Profile Avatar - Palmy Investing

Gain Therapeutics, Inc.

Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancemen…

Biotechnology
US, Bethesda [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of GANX's Analysis
CIK: 1819411 CUSIP: 36269B105 ISIN: US36269B1052 LEI: - UEI: -
Secondary Listings
GANX has no secondary listings inside our databases.